| 000 | 01552 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512005011.0 | ||
| 264 | 0 | _c19890803 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0009-9120 | ||
| 024 | 7 |
_a10.1016/s0009-9120(89)80076-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaust, H L | |
| 245 | 0 | 0 |
_aIntramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning. _h[electronic resource] |
| 260 |
_bClinical biochemistry _cJun 1989 |
||
| 300 |
_a189-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChelating Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aFerritins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aIron-Dextran Complex _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 |
_aLead Poisoning _xblood |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOccupational Diseases _xblood |
| 650 | 0 | 4 |
_aPorphobilinogen Synthase _xmetabolism |
| 650 | 0 | 4 |
_aProtoporphyrins _xanalysis |
| 650 | 0 | 4 | _aSpectrophotometry, Atomic |
| 650 | 0 | 4 |
_aSuccimer _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aInwood, M | |
| 700 | 1 | _aSpence, J D | |
| 700 | 1 | _aPoon, H C | |
| 700 | 1 | _aPeter, F | |
| 773 | 0 |
_tClinical biochemistry _gvol. 22 _gno. 3 _gp. 189-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0009-9120(89)80076-1 _zAvailable from publisher's website |
| 999 |
_c2550279 _d2550279 |
||